UHRF2 and neoplasm: Varley and colleagues analyzed promoter methylation of each of the 100 “CAN” genes identified as mutated in breast and colon cancer and found that UHRF2 was one of only 5 genes that was methylated in both tumor types but not normal matched tissue [38].